Works matching IS 15330028 AND DT 2024 AND VI 23 AND IP 1
Results: 12
Neoadjuvant Immunotherapy With Ipilimumab Plus Nivolumab in Mismatch Repair Deficient/Microsatellite Instability-High Colorectal Cancer: A Preliminary Report of Case Series.
- Published in:
- Clinical Colorectal Cancer, 2024, v. 23, n. 1, p. 104, doi. 10.1016/j.clcc.2024.01.002
- By:
- Publication type:
- Article
Adjuvant Chemotherapy for Older Patients With Stage III Colorectal Cancer: A Real-World Analysis ofTreatment Recommendations, Treatment Administered and Impact on Cancer Recurrence.
- Published in:
- Clinical Colorectal Cancer, 2024, v. 23, n. 1, p. 95, doi. 10.1016/j.clcc.2024.01.001
- By:
- Publication type:
- Article
Salvage Treatment of Recurrent or Persistent Anal Squamous Cell Carcinoma: The Role of Multi-modality Therapy.
- Published in:
- Clinical Colorectal Cancer, 2024, v. 23, n. 1, p. 85, doi. 10.1016/j.clcc.2023.12.002
- By:
- Publication type:
- Article
Prognostic Impact of Primary Tumor blaedness in Stage III Colorectal Cancer: Real-World Evidence from a Brazilian Cohort.
- Published in:
- Clinical Colorectal Cancer, 2024, v. 23, n. 1, p. 73, doi. 10.1016/j.clcc.2023.12.001
- By:
- Publication type:
- Article
A Phase 1 Study of Cabozantinib and Trinurlaine/Tipiracil in Metastatic Colorectal Acienocarcinoma.
- Published in:
- Clinical Colorectal Cancer, 2024, v. 23, n. 1, p. 67, doi. 10.1016/j.clcc.2023.11.001
- By:
- Publication type:
- Article
Efficacy of Pyrotinib With/Without Trastuzumab in Treatment-Refractory, HER2-Positive Metastatic Colorectal Cancer: Result From a Prospective Observational Study.
- Published in:
- Clinical Colorectal Cancer, 2024, v. 23, n. 1, p. 58, doi. 10.1016/j.clcc.2023.10.008
- By:
- Publication type:
- Article
Real-World Safety and Effectiveness of a Bevacizumab Biosimilar (ABP 215) in Metastatic Colorectal Cancer Patients in Canada.
- Published in:
- Clinical Colorectal Cancer, 2024, v. 23, n. 1, p. 46, doi. 10.1016/j.clcc.2023.10.007
- By:
- Publication type:
- Article
Propensity-Score Matched Analysis of Survival Outcomes of Adjuvant Therapy in Stage II-III Signet-Ring Cell Carcinoma of the Colon.
- Published in:
- Clinical Colorectal Cancer, 2024, v. 23, n. 1, p. 35, doi. 10.1016/j.clcc.2023.10.006
- By:
- Publication type:
- Article
Optimizing Fecal Occult Blood Test (FOBT) Colorectal Cancer Screening Using Gut Bacteriome as a Biomarker.
- Published in:
- Clinical Colorectal Cancer, 2024, v. 23, n. 1, p. 22, doi. 10.1016/j.clcc.2023.10.004
- By:
- Publication type:
- Article
Effectiveness of Biologic Agents Among Hispanic Patients With Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2024, v. 23, n. 1, p. 14, doi. 10.1016/j.clcc.2023.10.001
- By:
- Publication type:
- Article
Clinical Management of Gastrointestinal and Liver Toxicities of Immune Checkpoint Inhibitors.
- Published in:
- Clinical Colorectal Cancer, 2024, v. 23, n. 1, p. 4, doi. 10.1016/j.clcc.2023.12.003
- By:
- Publication type:
- Article
Cost-Effectiveness of the New Combination Trifluridine/Tipiracil Plus Bevacizumab for the Third-Line Treatment for Metastatic Colorectal Cancer in Italy.
- Published in:
- Clinical Colorectal Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1016/j.clcc.2023.10.005
- By:
- Publication type:
- Article